Plain-English translation of NCT06850038 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term observational study that follows people with Alagille syndrome (a rare liver disease that causes itching and liver damage) as they take odevixibat in their daily lives. Researchers want to understand how well this medication works and how safe it is when used over time in real-world conditions, not just in controlled clinical trials.
While this medication has been tested in clinical trials, researchers want to gather information about how it performs and what side effects patients experience over the long term in everyday use. This real-world data helps doctors understand whether this treatment is truly helping patients with this rare disease.
You likely qualify if…
You likely don't qualify if…
As a participant, you would continue taking your medication as prescribed while researchers regularly collect information about your health, how you are feeling, and any side effects you experience. This involves sharing your medical information and possibly completing check-ins or surveys over an extended period. The study is designed to fit into your normal routine rather than requiring frequent hospital visits.
AI-generated summary from trial data · Nov 10, 2026 · Not medical advice
United States